-
Evaluation of Real-World Data Landscape in the United Kingdom: A Scoping Review
Sep 9, 2025, 16:22 PM -
Psychometric Performance of EQ-HWB for Japanese Populations
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Multiplex Cell Culture Technology for Predicting Carboplatin Plus Paclitaxel-Induced Side Effects in Cancer Care
Sep 9, 2025, 16:22 PM -
Navigating Large Evidence Bases for MTEP Submissions and for the New NICE HealthTech Program
Sep 9, 2025, 16:22 PM -
Limited Duration vs. Treat-to-Progression Approaches for New Therapies in Hemato-oncology: Impact at HTA
Sep 9, 2025, 16:22 PM -
Cost Savings From Patient Preference-Based Allocation of High-Efficacy Therapies for MS: Evidence From Switzerland
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Pancreatic Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service
Sep 9, 2025, 16:22 PM -
Increases in Frailty Following Hospitalization With COVID-19: An Analysis of Claims and Annual Health Check Data
Sep 9, 2025, 16:22 PM -
Do Health Technology Assessments (HTA) Consider Racial Health Inequalities? A Case Study of NICE HTAs for Chronic Kidney Disease Hypertension and Diabetes
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Measured by EQ-5D Utility Among Patients With TGCT: A Trial-Based Analysis of EQ-5D Data From Patients in the MOTION Trial
Sep 9, 2025, 16:22 PM -
Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions
Sep 9, 2025, 16:22 PM -
The Rise of Optimization in NICE Guidance: A Two-Decade Review With a Focus on Prevention
Sep 9, 2025, 16:22 PM -
Foregone Net Monetary Benefit From Underdiagnosis and Undertreatment of Mild Cognitive Impairment Due to Alzheimer’s Disease in the Medicare Population
Sep 9, 2025, 16:22 PM -
Patient-Centered Hearing Technology Assessment: Integrating ICF Into Multicriteria Decision Making
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis With Subgroup Analyses by Population Type
Sep 9, 2025, 16:22 PM -
Real-World Differences in Breast Cancer Management by Detection Method: A Czech National Analysis
Sep 9, 2025, 16:22 PM -
NICE Technology Appraisal Submissions for Non-Small Cell Lung Cancer: Analysis and Insights
Sep 9, 2025, 16:22 PM
